ArticleInternational urology and nephrology2026

Bladder preservation with disitamab vedotin plus PD-1 inhibitors and local intensification in muscle-invasive bladder cancer: a single-center retrospective cohort of 81 patients.

Yan Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.